In addition to announcing preliminary unaudited fourth quarter and full year 2022 revenue, Deciphera Pharmaceuticals, Inc., a biopharmaceutical company dedicated to discovering, developing, and commercialising significant new medicines to improve the lives of people with cancer, today highlighted its strategic outlook for 2023 and planned 2023 corporate milestones. Deciphera revealed […]
Featured News
Community Health System and Health Net Agree on Multi-year Network Contract
In order to better serve the inhabitants of Fresno county, Health Net and Community Health System have announced they will maintain their long-standing cooperation. Existing and prospective Health Net members registered in commercial, Medicare, and Medi-Cal plans will still have access to the full range of services provided by Community. […]
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
The COVID-19-Influenza Combination (CIC) and influenza stand-alone vaccine candidates will now be tested in a Phase 2 trial, according to Novavax, Inc., a biotechnology company committed to creating and marketing next-generation vaccines for critical infectious diseases. The CIC and influenza vaccine candidates will be evaluated for safety and efficacy (immunogenicity) […]
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances
Telix Pharmaceuticals Limited reports that an oral presentation of the recently finished pivotal Phase III ZIRCON study of TLX250-CDx (Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRCC) will take place at the upcoming 2023 ASCO GU Symposium, which will take place in San Francisco, California, from February 16–18, 2023. The […]
National Council on Aging Launches Coordinated Effort to Promote COVID and Flu Vaccinations
The U.S. Administration for Community Living has awarded a $50 million funding to the National Council on Aging (NCOA), the voice for everyone’s right to age well, to launch a national effort to ensuring that older folks and people with disabilities obtain the most recent COVID and flu vaccines. The […]
Carrick Therapeutics and The Menarini Group Announce Collaboration on Clinical Trials to Evaluate Samuraciclib and Elacestrant Combination
The Menarini Group, a renowned international private equity pharmaceutical company private sector, and Carrick Therapeutics, an oncology-focused biopharmaceutical company that discovers and develops highly distinct therapies, today announced a clinical trial collaboration and supply agreement. This agreement covers the conduct of a Phase 2 clinical trial to assess Carrick’s novel […]
Saluda Medical Initiates U.S. Commercialization of the Evoke® Spinal Cord Stimulation System
Evoke® Spinal Cord Stimulation System: The first and only SmartSCSTM in the United States, the Evoke® System, has begun to be sold, according to Saluda Medical Pty Limited (“Saluda Medical”), a global medical device firm redefining the field of neuromodulation. The limited commercial release (LCR) of the Evoke System in […]
Kaiser Permanente study shows that, More exercise linked to less-severe COVID-19 outcomes
A study published on December 15, 2022 in the American Journal of Preventive Medicine found that COVID-19 patients at Kaiser Permanente who were more physically active before receiving a diagnosis had a lower probability of serious consequences. Regardless of whether patients had chronic medical issues, the study of almost 200,000 […]
Pfizer Scientists Are Doubling Down To Conquer Blood Disorders
Blood disorders affect millions of people worldwide today. Because of this, this December, experts in the field of blood disorders from all over the world will assemble in New Orleans for the 64th Annual Meeting of the American Society of Hematology (ASH), an organisation dedicated to curing blood disorders. Pfizer […]
Kedrion Expands Its System Of Plasma Gathering Facilities
The acquisition of the Czech firms UNICAplasma sro and UNICAplasma Morava sro, which run five plasma collection centres in the Czech Republic, was announced by Kedrion, an Italian global biopharmaceutical company that collects and fractionates blood plasma to make and distribute plasma-derived drugs for the treatment of serious diseases and […]
